Exploring the correlates of intermediate CAG repeats in Huntington disease

Postgraduate Medicine

Volumn 123, Issue 5, 2011, Pages 116-121

  Ha, Ainhi D ^a   Jankovic, Joseph ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Chorea; Genetic counseling; Huntingtin gene; Huntington disease; Intermediate repeats; Trinucleotide repeats

Indexed keywords

ALPRAZOLAM; PAROXETINE; TETRABENAZINE;

ADULT; AGED; ALLELE; ANXIETY DISORDER; ARTICLE; ATROPHY; BEHAVIOR CHANGE; BIPOLAR DISORDER; CAG REPEAT; CASE REPORT; COGNITIVE DEFECT; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSARTHRIA; DYSPHAGIA; FEMALE; FLUENCY DISORDER; GAIT DISORDER; GENE; GENETIC ASSOCIATION; GENETIC SCREENING; GLIOSIS; HUMAN; HUNTINGTIN GENE; HUNTINGTON CHOREA; IRRITABILITY; MALE; MEMORY DISORDER; MOTOR DYSFUNCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PSYCHOMOTOR DISORDER; PSYCHOSOCIAL WITHDRAWAL; SACCADIC EYE MOVEMENT; SEQUENCE ANALYSIS; SHORT TERM MEMORY; SPINOCEREBELLAR DEGENERATION; TONGUE PARALYSIS;

AGE OF ONSET; AGED; ALLELES; FEMALE; HUMANS; HUNTINGTON DISEASE; MALE; MIDDLE AGED; RISK FACTORS; TRINUCLEOTIDE REPEATS;

EID: 80052769417     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2011.09.2466     Document Type: Article

References (27)

1. Fahn S, Jankovic J. Huntington disease. In: LP Rowland, ed. Merritt's Textbook of Neurology. Philadelphia, PA: Wolters Kluwer/Lippincott, Williams and Wilkins, 2010:723-726.
2. Semaka A, Creighton S, Warby S, Hayden MR. Predictive testing for Huntington disease: interpretation and significance of intermediate alleles. Clin Genet. 2006;70(4):283-294.
3. Novak MJ, Tabrizi SJ. Huntington's disease. BMJ. 2010;340:c3109.
4. Herishanu YO, Parvari R, Pollack Y, et al. Huntington disease in subjects from an Israeli Karaite community carrying alleles of intermediate and expanded CAG repeats in the HTT gene: Huntington disease or phenocopy? J Neurol Sci. 2009;277(1-2):143-146.
5. Groen JL, de Bie RM, Foncke EM, Roos RA, Leenders KL, Tijssen MA. Late-onset Huntington disease with intermediate CAG repeats: true or false? J Neurol Neurosurg Psychiatry. 2010;81(2):228-230.
6. Andrich J, Arning L, Wieczorek S, Kraus PH, Gold R, Saft C. Huntington's disease as caused by 34 CAG repeats. Mov Disord. 2008;23:879-881.
7. Kenney C, Powell S, Jankovic J. Autopsy-proven Huntington's disease with 29 trinucleotide repeats. Mov Disord. 2007;22(1):127-130.
8. Kenney C, Jankovic J. Re: Autopsy-proven Huntington's disease with 29 trinucleotide repeats. Mov Disord. 2008;23(12):1795-1796.
9. Andrew SE, Goldberg YP, Kremer B, et al. Huntington disease without CAG expansion: phenocopies or errors in assignment? Am J Hum Genet. 1994;54(5):852-863.
10. Wild EJ, Tabrizi SJ. Huntington's disease phenocopy syndromes. Curr Opin Neurol. 2007;20(6):681-687.
11. Biglan KM, Jankovic J, Eberly S, et al. Longitudinal analysis of intermediate CAGn repeat length expansion in the Prospective Huntington Disease At-Risk Observational Study (PHAROS) [abstract]. Mov Disord. 2010.
12. Ha A, Davidson A, Jankovic J. Intermediate CAG repeats: analysis of the Cooperative Huntington's Observational Research Trial. Neurotherapeutics. 2011;8:145.
13. Quarrell OW, Rigby AS, Barron L, et al. Reduced penetrance alleles for Huntington's disease: a multi-centre direct observational study. J Med Genet. 2007;44(3):e68.
14. Walker FO. Huntington's disease. Lancet. 2007;369(9557):218-228.
15. Wexler NS, Lorimer J, Porter J, et al; U.S.-Venezuela Collaborative Research Project. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. Proc Natl Acad Sci USA. 2004;101(10):3498-3503.
16. Alford RL, Ashizawa T, Jankovic J, Caskey CT, Richards CS. Molecular detection of new mutations, resolution of ambiguous results and complex genetic counseling issues in Huntington disease. Am J Med Genet. 1996;66:281-286.
17. Sequeiros J, Ramos EM, Cerqueira J, et al. Large normal and reduced penetrance alleles in Huntington disease: instability in families and frequency at the laboratory, at the clinic and in the population. Clin Genet. 2010;78(4):381-387.
18. McNicoll CF, Latourelle JC, MacDonald ME, et al. Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: the GenePD study. Mov Disord. 2008;23(11):1596-1601.
19. Goldberg YP, McMurray CT, Zeisler J, et al. Increased instability of intermediate alleles in families with sporadic Huntington disease compared to similar sized intermediate alleles in the general population. Hum Mol Genet. 1995;4(10):1911-1918.
20. Chong SS, Almqvist E, Telenius H, et al. Contribution of DNA sequence and CAG size to mutation frequencies of intermediate alleles for Huntington disease: evidence from single sperm analyses. Hum Mol Genet. 1997:6(2):301-309.
21. Kovtun IV, Liu Y, Bjoras M, Klungland A, Wilson SH, McMurray CT. OGG1 initiates age-dependent CAG trinucleotide expansion in somatic cells. Nature. 2007;447(7143):447-452.
22. Swami M, Hendricks AE, Gillis T, et al. Somatic expansion of the Huntington's disease CAG repeat in the brain is associated with an earlier age of disease onset. Hum Mol Genet. 2009;18(16):3039-3047.
23. Gonitel R, Moffitt H, Sathasivam K, et al. DNA instability in postmitotic neurons. Proc Natl Acad Sci USA. 2008;105(9):3467-3472.
24. Lagier-Tourenne C, Cleveland DW. Neurodegeneration: an expansion in ALS genetics. Nature. 2010;466(7310):1052-1053.
25. Elden AC, Kim HJ, Hart MP, et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature. 2010;466(7310):1069-1075.
26. Hendricks AE, Latourelle JC, Lunetta KL, et al. Estimating the probability of de novo HD cases from transmissions of expanded penetrant CAG alleles in the Huntington disease gene from male carriers of high normal alleles (27-35 CAG). Am J Med Genet. 2009;149 A:1375-1381.
27. Squitieri F, Esmaeilzadeh M, Ciarmiello A, Jankovic J. Caudate glucose hypometabolism in a subject carrying an unstable allele of intermediate CAG(33) repeat length in the Huntington's disease gene. Mov Disord. 2011;26(5):925-927.